Drug Promotion
More Information on Drug Promotion
- Comments to the FDA Endorsing a Citizen Petition Submitted by Knowledge Ecology International Requesting a Ban on the Use of Background Music During the Presentation of Risks in Direct-to-Consumer Drug Broadcast Advertising, October 27, 2020
- Comments to the FDA on the Presentation of Risk Information in Prescription Drug Direct-to-Consumer Broadcast Ads, November 20, 2017
- Testimony Before the FDA’s Public Hearing on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products, November 9, 2016
- Press Statement: Lawmakers’ Proposal Would Turn Patients Into Guinea Pigs, May 27, 2016
- Letter to FDA on the Off-Label Promotion of Several Diabetes Drugs, March 31, 2015
- Public Citizen Comment on Corrective Ad Study, April 27, 2012
- Comments to FDA on Direct-to-Consumer Drug Advertisements, February 27. 2012
- Letter on Regulation of Direct-to-Consumer Marketing, June 28, 2010
- Allergan v. FDA (Can the FDA enforce regulations that restrict the promotion of off-label uses?), December 21, 2009
- Article in JLME: DTC Advertising Harms Patients and Should Be Tightly Regulated, September 2009
- Comments on Draft Guidance for Industry on Off-Label Promotion of Drugs and Medical Devices, April 21, 2008
- Letter Urging Action Against a Campaign Promoting the Unapproved Use of Topiramate (Topamax) for Treating Alcoholics, October 9, 2007
- Letter Concerning Pfizer’s Television Advertisement for Celebrex, April 9, 2007
- Comments on Direct-to-Consumer Advertising of Prescription Drugs, April 28, 2006
- Article in Journal of Public Health Policy: Widespread Drug Marketing Violations Occurred at APA Convention, December 15, 2005
- Congressional Testimony on the Impact of Direct-to-Consumer Drug Advertising on Seniors, September 29, 2005
- Public Citizen v. Sorrell (Seeking records on an unapproved use of a drug), August 19, 2005
- Letter Urging Action on AstraZeneca’s Misleading Crestor Advertising, November 24, 2004
- Letter to Local Television Station General Managers and News Directors: Drug Ads Masquerading as News, July 9, 2004
- Public Citizen v. FDA (Seeking records on an unapproved use of a drug), February 26, 2004
- Comments on FDA Enforcement of Drug Advertising Regulations, October 28, 2002
- Comments on First Amendment Issues, September 13, 2002
- Letter in the BMJ on Disease Mongering, July 27, 2002
- Letter Requesting Ban on the Demonstration of Medical Interventions, July 12, 2002
- Letter Urging the Cancellation of “Botox Night”, July 9, 2002
- Article in NEJM on Direct-To-Consumer Advertising, February 14, 2002
- Testimony on Direct-to-Consumer (DTC) Advertising, July 24, 2001
- Letter on Drug Industry Influence on Medical Residents, April 26, 2001